Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Vitamin B2 and Reduced Seizure Frequency

Doses used in studies

mg/day: 100 (median 100, IQR 100–100) — 1 study

Time to effect

Median: 6.1 months · IQR 6.1 months–6.1 months · Range 6.1 months–6.1 months — Reported in 1 of 1 study

1 of 1 paper

Riboflavin treatment in L-2-hydroxyglutaric aciduria: report on a pediatric patient and literature review.
- 2025-05-17
- Review
- Journal of applied genetics 67(2)
- - Patryk Lipiński
  - Elżbieta Ciara
  - Anna Bogdańska
  - Elżbieta Jurkiewicz
  - Anna Tylki-Szymańska
- PubMed: 40380983
- DOI: 10.1007/s13353-025-00974-4
5 Insights on
- Reduced Seizure Frequency
- Low evidence
- Clinical
A 6-month period of treatment with riboflavin (100 mg/day) was implemented with no clinical nor biochemical effect.
Effect
Neutral
Effect size
Small
Significant
No
Dose
100 mg/day